25.97 M
About GeneThera, Inc.
Sector
Industry
Headquarters
Westminster
Website
Founded
1998
FIGI
BBG000PLQ792
GeneThera, Inc. is a biotechnology company that focuses on eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s disease), Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections by applying proprietary molecular sciences and technologies. The firm is working on novel molecular diagnostic tests, therapeutics, and vaccine solutions through robotic technologies to meet the demands of the veterinary, agriculture, and healthcare industries. The company was founded by Antonio Milici in November 1998 and is headquartered in Westminster, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GTHR is 0.000001 USD — it has decreased by 99.98% in the past 24 hours. Watch GeneThera, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GeneThera, Inc. stocks are traded under the ticker GTHR.
GTHR stock is 600.00 K% volatile and has beta coefficient of −0.43. Track GeneThera, Inc. stock price on the chart and check out the list of the most volatile stocks — is GeneThera, Inc. there?
Yes, you can track GeneThera, Inc. financials in yearly and quarterly reports right on TradingView.
No, GTHR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GTHR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GeneThera, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GTHR reached its all-time high on Oct 25, 1999 with the price of 186250.000000 USD, and its all-time low was 0.000001 USD and was reached on Feb 20, 2024. View more price dynamics on GTHR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GeneThera, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GeneThera, Inc. stock shows the strong sell signal. See more of GeneThera, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.